Loading...
OTCMSHPMY
Market cap8.68bUSD
Dec 23, Last price  
8.40USD
1D
5.00%
1Q
34.19%
Name

Shanghai Pharmaceuticals Holding Co Ltd

Chart & Performance

D1W1MN
OTCM:SHPMY chart
P/E
47.45
P/S
0.69
EPS
1.29
Div Yield, %
16.25%
Shrs. gr., 5y
5.49%
Rev. gr., 5y
10.35%
Revenues
260.30b
+12.21%
10,814,950,11010,699,340,91911,410,298,67413,919,791,22616,547,824,89819,568,123,84837,411,066,14354,899,872,50468,078,117,81978,222,817,35792,398,893,626105,516,587,303120,764,660,339130,847,181,884159,084,396,948186,565,796,464191,909,156,160215,824,259,035231,981,299,764260,295,088,942
Net income
3.77b
-32.92%
93,135,40050,523,25368,710,38166,278,12081,982,816173,332,5111,368,252,8692,042,238,4822,052,871,6982,242,925,1412,591,129,0732,876,989,1423,196,394,6443,520,645,5663,881,062,8614,080,993,6634,496,216,9585,093,467,2605,617,152,0033,767,999,581
CFO
5.23b
+10.29%
61,662,59973,002,128583,110,223488,940,577285,679,320664,133,6221,686,087,8031,772,438,0111,150,774,970973,449,6931,335,674,1351,349,162,8531,946,666,9852,648,808,8693,135,113,7636,022,385,6136,844,720,6255,061,326,2764,743,361,1815,231,519,727
Dividend
Sep 19, 20240.056 USD/sh
Earnings
Mar 26, 2025

Profile

Shanghai Pharmaceuticals Holding Co., Ltd., an investment holding company, researches, develops, manufactures, distributes, and retails pharmaceutical and healthcare products in the People's Republic of China. It operates through four segments: Production, Distribution, Retail, and Others. The company offers chemicals and biochemicals, Chinese medicines, healthcare products, and medical devices in various therapeutic areas, including oncology, cerebrocardiovascular, CNS, general infection, immunology, digestive and metabolism, and respiratory. It provides approximately 700 varieties of drugs. The company also engages in the provision of pharmaceutical distribution, warehousing, logistics, and other value-added pharmaceutical supply chain solutions and related services to pharmaceutical manufacturers and dispensers, such as hospitals, distributors, and retail pharmacies. In addition, it engages in the operation of a network of retail pharmacy stores; online drug business; and provision of consulting services, assets management operations, as well as clinical trials, medical aid, physicians and patients' education, e-prescription management, and remote and cloud hospitals. Further, the company manufactures and trades in medicines. It operates approximately 2,000 retail chain pharmacies in 24 provinces. The company was incorporated in 1994 and is headquartered in Shanghai, the People's Republic of China. Shanghai Pharmaceuticals Holding Co., Ltd. is a subsidiary of Shanghai Pharmaceutical (Group) Co., Ltd.
URL
https://www.sphchina.com/index/
IPO date
Mar 24, 1994
Employees
47,811
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑122015‑122014‑12
Income
Revenues
260,295,089
12.21%
231,981,300
7.49%
215,824,259
12.46%
Cost of revenue
242,070,319
219,082,765
203,995,917
Unusual Expense (Income)
NOPBT
18,224,770
12,898,534
11,828,342
NOPBT Margin
7.00%
5.56%
5.48%
Operating Taxes
1,887,726
1,816,339
1,869,245
Tax Rate
10.36%
14.08%
15.80%
NOPAT
16,337,043
11,082,196
9,959,097
Net income
3,768,000
-32.92%
5,617,152
10.28%
5,093,467
13.28%
Dividends
(3,981,205)
(1,552,494)
(1,364,203)
Dividend yield
6.43%
2.50%
2.42%
Proceeds from repurchase of equity
BB yield
Debt
Debt current
35,560,500
31,000,022
23,096,617
Long-term debt
8,886,308
8,863,022
10,026,300
Deferred revenue
633,481
534,581
2,349,080
Other long-term liabilities
922,510
296,175
605,101
Net debt
(7,368,365)
984,476
(1,045,790)
Cash flow
Cash from operating activities
5,231,520
4,743,361
5,061,326
CAPEX
(2,970,610)
Cash from investing activities
(2,491,873)
Cash from financing activities
231,851
12,138,594
1,565,628
FCF
11,288,093
2,857,009
9,653,573
Balance
Cash
40,669,861
37,014,951
22,390,386
Long term investments
11,145,311
1,863,617
11,778,321
Excess cash
38,800,418
27,279,502
23,377,493
Stockholders' equity
49,327,584
48,670,763
42,712,470
Invested Capital
85,344,916
88,674,314
68,638,880
ROIC
18.78%
14.09%
14.77%
ROCE
14.56%
11.02%
12.72%
EV
Common stock shares outstanding
3,701,294
3,482,740
2,842,089
Price
16.73
-6.17%
17.83
-10.27%
19.87
3.49%
Market cap
61,922,656
-0.28%
62,097,251
9.96%
56,472,315
3.49%
EV
66,356,241
74,021,172
65,133,255
EBITDA
20,411,901
15,120,975
13,968,146
EV/EBITDA
3.25
4.90
4.66
Interest
1,663,555
1,689,279
1,518,228
Interest/NOPBT
9.13%
13.10%
12.84%